Science
CRISPR editing of mitochondria: Promising new biotech? – Phys.org
Although the CRISPR/Cas9 system has seen widespread application in editing the nuclear genome, using it to edit the mitochondrial genome has been problematic. The…
Although the CRISPR/Cas9 system has seen widespread application in editing the nuclear genome, using it to edit the mitochondrial genome has been problematic. The main hurdles have been a lack of suitable editing sites in the small mtDNA, and the traditional difficulty of importing the guide RNA into the mitochondrial matrix where nucleoids can be accessed.
Two recently published papers suggest that significant progress is being made on both fronts. The first paper, published in the journal SCIENCE…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News24 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025
-
Business23 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!